Description
This model achieves the goal of MHC-I knockout and GvHD reduction in hu-PBL mice (mice treated with PBMCs) by silencing H2-Db/H2-Kd.
Applications
Human-specific infectious diseases; Antibody-based immune therapy; Human-specific vaccine development; Cell-based adoptiive immunity
Strain Name
NSG (Db/Kd null)